Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ACE | P12821 | 2/20 | 0.53 |
| ▸ | FFAR2 | O15552 | 10/20 | 0.45 |
| ▸ | LMNA | P02545 | 1/20 | 0.41 |
| ▸ | HTT | P42858 | 1/20 | 0.41 |
| ▸ | POLB | P06746 | 2/20 | 0.39 |
| ▸ | GAA | P10253 | 1/20 | 0.39 |
| ▸ | RAB9A | P51151 | 1/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.39 |
| ▸ | HPGD | P15428 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10999352 | 0.92 | ACE (0.52) | ACEFFAR2LMNAHTTPOLB | |
| SCHEMBL11195287 | 0.90 | ACE (0.52) | ACEFFAR2LMNAHTTPOLB | |
| SCHEMBL10944250 | 0.89 | ACE (0.53) | ACEFFAR2LMNAHTTPOLB | |
| SCHEMBL10995338 | 0.87 | ACE (0.47) | ACEFFAR2LMNA | |
| SCHEMBL11267042 | 0.82 | ACE (0.53) | ACEFFAR2LMNAHTTPOLB | |
| SCHEMBL10969779 | 0.82 | ACE (0.77) | ACEFFAR2LMNAHTTPOLB | |
| SCHEMBL10979196 | 0.82 | ACE (0.77) | ACEFFAR2LMNAHTTPOLB | |
| SCHEMBL11185062 | 0.82 | ACE (0.77) | ACEFFAR2LMNAHTTPOLB | |
| SCHEMBL11075093 | 0.82 | ACE (0.54) | ACEFFAR2LMNAHTTPOLB | |
| SCHEMBL10999357 | 0.82 | ACE (0.49) | ACEFFAR2LMNAHTTPOLB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-4347371-A | HYPERTENSIVE AGENTS; ANTIDIABETIC AGENTS; VISION DEFECTS | SANTEN PHARMACEUTICAL CO., LTD. (JP) | 1982-08-31 | — | — | US | claimed |
| US-4410542-A | HYPOTENSIVE AGENTS, PYRROLINE-1,2-DICARBOXYLIC ACID DERIVATIVES | SANTEN PHARMACEUTICAL CO., LTD. (JP) | 1983-10-18 | — | — | US | disclosed |
| US-4347371-A | HYPERTENSIVE AGENTS; ANTIDIABETIC AGENTS; VISION DEFECTS | SANTEN PHARMACEUTICAL CO., LTD. (JP) | 1982-08-31 | — | — | US | disclosed |